iSpecimen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.34	15.31	27.74	0.7	0.05
Short-Term Investments	2.66	0	0	0	0
Cash & Cash Equivalents	5.01	15.31	27.74	0.7	0.05
Cash Growth	-67.30%	-44.81%	3886.01%	1191.28%	-
Receivables	2.94	3.93	4.74	2.18	1.29
Other Current Assets	0.29	0.44	0.47	0.6	0.24
Total Current Assets	8.24	19.68	32.95	3.47	1.58
Property, Plant & Equipment	0.32	0.41	0.03	0.08	0.12
Goodwill and Intangibles	7.23	4.5	2.71	2.63	2.31
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.21
Total Long-Term Assets	7.58	4.94	2.77	2.74	2.63
Total Assets	15.82	24.62	35.72	6.21	4.21
Accounts Payable	3.93	2.46	0.83	1.79	0.74
Deferred Revenue	0.42	0.13	0.65	0.87	0
Current Debt	0.17	0.16	0	12.59	10.59
Other Current Liabilities	1.54	1.53	1.02	6.88	4.43
Total Current Liabilities	6.05	4.28	2.51	22.14	15.76
Long-Term Debt	0.03	0.03	3.42	0.18	0
Total Long-Term Liabilities	0.03	0.03	3.42	0.18	0
Total Liabilities	6.08	4.31	5.93	22.31	15.76
Total Debt	0.2	0.19	3.42	12.77	10.59
Debt Growth	5.59%	-94.57%	-73.19%	20.55%	-
Retained Earnings	-59.36	-48.27	-38.02	-29.06	-24.41
Comprehensive Income	0	0	0	0	0
Shareholders' Equity	9.74	20.31	29.79	-27.28	-22.72
Net Cash / Debt	4.81	15.12	24.32	-12.07	-10.54
Net Cash / Debt Growth	-68.20%	-37.81%	-	-	-
Net Cash Per Share	0.53	1.71	5.67	-12.89	-11.26
Working Capital	2.19	15.39	30.44	-18.66	-14.18
Book Value Per Share	1.08	2.30	6.95	-29.14	-24.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).